Dr Philippa Cheetham is a board certified UK trained Urologist, having completed general surgery and urology residency at Oxford University, UK and urology fellowship training at Columbia University Medical Center, New York, USA. She treats both male and female urology patients and has a strong interest in integrative and holistic medicine. Dr Cheetham has a special interest in the management of prostate cancer as well as female urology. As well as treating many patients with kidney stones, she also has...Read More
Dr Philippa Cheetham is a board certified UK trained Urologist, having completed general surgery and urology residency at Oxford University, UK and urology fellowship training at Columbia University Medical Center, New York, USA. She treats both male and female urology patients and has a strong interest in integrative and holistic medicine. Dr Cheetham has a special interest in the management of prostate cancer as well as female urology. As well as treating many patients with kidney stones, she also has expertise in neurological conditions that affect the bladder. Dr Cheetham also offers telephone consults through her website drcheetham.com for patients who do not live locally.
Clinical and Biochemical Outcomes of High-Risk Prostate Cancer Patients treated with Third Generation Prostate Cryoablation- with and without neoadjuvant hormones S Wenske, PJ Cheetham, AE Katz Journal of Analytical Oncology 2013 (Vol 2) No 2...Read More
Clinical and Biochemical Outcomes of High-Risk Prostate Cancer Patients treated with Third Generation Prostate Cryoablation- with and without neoadjuvant hormones S Wenske, PJ Cheetham, AE Katz Journal of Analytical Oncology 2013 (Vol 2) No 2 p120-7
Tubulin targeted agents including docetaxol and cabazitaxel PJ Cheetham and DP Petrylak The Cancer Journal. Special Edition on New Agents for Prostate Cancer 2013 19 (1) p59-65
Update on Diet and Nutrition in Prostate Cancer PJ Cheetham AUA news December 2012 edition pages 11-12 Guest Editor Gopal Badlani.
Abiraterone and increased survival in metastatic prostate cancer PJ Cheetham and DP Petrylak Eur Urol. 2012 Apr;61(4):850
Alpha Particles as Alpha-pharmaceuticals in the Treatment of Bone Metastases: Mechanism of Action of Alpharadin and Radiation Protection. Review Article PJ Cheetham and DP Petrylak Oncology 2012 Apr;26(4):330-7, 341.
